SCHEMBL5836244

SCHEMBL5836244

CC(=O)Nc1ccc(N[C@@H]2C[C@H](C)N(C(C)=O)c3ccc(Cl)cc32)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 16/20 0.67
BRD2 P25440 13/20 0.67
BRD3 Q15059 12/20 0.67
TRIM24 O15164 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2C9 P11712 1/20 0.67
TAF1 P21675 1/20 0.67
CYP2C19 P33261 1/20 0.67
EP300 Q09472 1/20 0.67
BRDT Q58F21 1/20 0.67
PBRM1 Q86U86 1/20 0.67
TAF1L Q8IZX4 1/20 0.67
CREBBP Q92793 1/20 0.67
BRWD1 Q9NSI6 1/20 0.67
TRIM33 Q9UPN9 1/20 0.67
CCL2 P13500 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5836236 1.00 BRD4 (0.67) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5836239 1.00 BRD4 (0.67) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL221204 0.93 BRD4 (0.70) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5837533 0.93 BRD4 (0.75) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5837528 0.93 BRD4 (0.75) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL20288818 0.92 BRD4 (0.80) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5836780 0.90 BRD4 (0.69) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5836786 0.90 BRD4 (0.69) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5836774 0.90 BRD4 (0.69) BRD4BRD2BRD3TRIM24CYP3A4
SCHEMBL5835845 0.87 BRD4 (0.71) BRD4BRD2BRD3TRIM24CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030246-B2 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof ASTRAZENECA AB (SE) 2006-04-18 US disclosed
US-20040132724-A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof ASTRAZENECA AB (SE) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132724-A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof STAT6, HRH4, HRH1 BRD4 39/4885BRD2 153/4885BRD3 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.